Related references
Note: Only part of the references are listed.Different profile of cytokine production in patients with systemic sclerosis and association with clinical manifestations
Andrea Tavares Dantas et al.
IMMUNOLOGY LETTERS (2018)
Scleroderma-like skin changes induced by checkpoint inhibitor therapy
B. Joel Tjarks et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2018)
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Proteomic Analysis of Sera from Individuals with Diffuse Cutaneous Systemic Sclerosis Reveals a Multianalyte Signature Associated with Clinical Improvement during Imatinib Mesylate Treatment
D. James Haddon et al.
JOURNAL OF RHEUMATOLOGY (2017)
Scleroderma Induced by Pembrolizumab: A Case Series
Naiara S. Barbosa et al.
MAYO CLINIC PROCEEDINGS (2017)
Contribution of Soluble Forms of Programmed Death 1 and Programmed Death Ligand 2 to Disease Severity and Progression in Systemic Sclerosis
Takemichi Fukasawa et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities
John Varga et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2017)
Abatacept: A Review in Rheumatoid Arthritis
Hannah A. Blair et al.
DRUGS (2017)
Macrophage Involvement in Systemic Sclerosis: Do We Need More Evidence?
Giuseppina Stifano et al.
CURRENT RHEUMATOLOGY REPORTS (2016)
Treatment with abatacept prevents experimental dermal fibrosis and induces regression of established inflammation-driven fibrosis
Matthieu Ponsoye et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Serum levels of soluble programmed death-1 and programmed death ligand-1 in systemic sclerosis: Association with extent of skin sclerosis
Koichi Yanaba et al.
JOURNAL OF DERMATOLOGY (2016)
Capillaroscopic findings and vascular biomarkers in systemic sclerosis: Association of low CD40L levels with late scleroderma pattern
Yasemin Yalcinkaya et al.
MICROVASCULAR RESEARCH (2016)
OX40L blockade protects against inflammation-driven fibrosis
Muriel Elhai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
CTLA4 blockade reduces immature myeloid cells in head and neck squamous cell carcinoma
Guang-Tao Yu et al.
ONCOIMMUNOLOGY (2016)
Emerging strategies for treatment of systemic sclerosis
Dinesh Khanna et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2016)
Epigenetic mechanisms: An emerging role in pathogenesis and its therapeutic potential in systemic sclerosis
Yangyang Luo et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2015)
Increased CD226 Expression on CD8+ T Cells Is Associated with Upregulated Cytokine Production and Endothelial Cell Injury in Patients with Systemic Sclerosis
Masahiro Ayano et al.
JOURNAL OF IMMUNOLOGY (2015)
Gene expression changes reflect clinical response in a placebo-controlled randomized trial of abatacept in patients with diffuse cutaneous systemic sclerosis
Eliza F. Chakravarty et al.
ARTHRITIS RESEARCH & THERAPY (2015)
The PD-1/PD-Ls pathway and autoimmune diseases
Suya Dai et al.
CELLULAR IMMUNOLOGY (2014)
Abatacept induces clinical improvement in patients with severe systemic sclerosis
F. V. de Paoli et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2014)
Activation of Toll-like Receptor-2 by Endogenous Matrix Metalloproteinase-2 Modulates Dendritic-Cell-Mediated Inflammatory Responses
Emmanuelle Godefroy et al.
CELL REPORTS (2014)
Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study
Muriel Elhai et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Critical role of the adhesion receptor DNAX accessory molecule-1 (DNAM-1) in the development of inflammation-driven dermal fibrosis in a mouse model of systemic sclerosis
Jerome Avouac et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Increased production of soluble inducible costimulator in patients with diffuse cutaneous systemic sclerosis
Koichi Yanaba et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2013)
The CTLA-4 and MCP-1 Polymorphisms and Susceptibility to Systemic Sclerosis: a Meta-analysis
Gwan Gyu Song et al.
IMMUNOLOGICAL INVESTIGATIONS (2013)
Augmented ICOS expression in patients with early diffuse cutaneous systemic sclerosis
Minoru Hasegawa et al.
RHEUMATOLOGY (2013)
DNA demethylation of CD40l in CD4+ T cells from women with systemic sclerosis A possible explanation for female susceptibility
XiaoRi Lian et al.
ARTHRITIS AND RHEUMATISM (2012)
Matrix Metalloproteinases: A Review of Their Structure and Role in Systemic Sclerosis
Wen-jia Peng et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2012)
Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies
Muriel Elhai et al.
RHEUMATOLOGY (2012)
A multicenter study confirms CD226 gene association with systemic sclerosis-related pulmonary fibrosis
Lara Bossini-Castillo et al.
ARTHRITIS RESEARCH & THERAPY (2012)
A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort
Lara Bossini-Castillo et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Association of the CD226 Ser307 Variant With Systemic Sclerosis Evidence of a Contribution of Costimulation Pathways in Systemic Sclerosis Pathogenesis
P. Dieude et al.
ARTHRITIS AND RHEUMATISM (2011)
Indispensable roles of OX40L-derived signal and epistatic genetic effect in immune-mediated pathogenesis of spontaneous pulmonary hypertension
Moloud Rabieyousefi et al.
BMC IMMUNOLOGY (2011)
Matrix Metalloproteinse-2 Conditions Human Dendritic Cells to Prime Inflammatory TH2 Cells via an IL-12-and OX40L-Dependent Pathway
Emmanuelle Godefroy et al.
CANCER CELL (2011)
Costimulatory pathways in transplantation
Nina Pilat et al.
SEMINARS IN IMMUNOLOGY (2011)
Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis
Pravitt Gourh et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Safety Profile of Abatacept in Rheumatoid Arthritis: A Review
Majed Khraishi et al.
CLINICAL THERAPEUTICS (2010)
The soluble CTLA-4 receptor and its role in autoimmune diseases: an update
Daniele Saverino et al.
AUTOIMMUNITY HIGHLIGHTS (2010)
Molecular mechanisms of T-cell receptor and costimulatory molecule ligation/blockade in autoimmune disease therapy
Joseph R. Podojil et al.
IMMUNOLOGICAL REVIEWS (2009)
Transforming growth factor β as a therapeutic target in systemic sclerosis
John Varga et al.
NATURE REVIEWS RHEUMATOLOGY (2009)
Increased Serum Soluble OX40 in Patients with Systemic Sclerosis
Kazuhiro Komura et al.
JOURNAL OF RHEUMATOLOGY (2008)
T-cell co-stimulatory pathways in autoimmunity
Joerg J. Goronzy et al.
ARTHRITIS RESEARCH & THERAPY (2008)
High expression of CD40 on skin fibroblasts from patients with systemic sclerosis
Jae-Bum Jun et al.
RHEUMATOLOGY INTERNATIONAL (2007)
ICOS and B7 costimulatory molecule expression identifies activated cellular subsets in rheumatoid arthritis
Jeffrey H. Ruth et al.
CYTOMETRY PART A (2007)
Scleroderma: from cell and molecular mechanisms to disease models
DJ Abraham et al.
TRENDS IN IMMUNOLOGY (2005)
Increased plasma soluble CD40 ligand concentrations in systemic sclerosis and association with pulmonary arterial hypertension and digital ulcers
Y Allanore et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Detection of circulating soluble CD28 in patients with systemic lupus erythematosus, primary Sjogren's syndrome and systemic sclerosis
M Hebbar et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Involvement of inducible costimulator in the exaggerated memory B cell and plasma cell generation in systemic lupus erythematosus
A Hutloff et al.
ARTHRITIS AND RHEUMATISM (2004)
Serum soluble CTLA-4 levels are increased in diffuse cutaneous systemic sclerosis
S Sato et al.
RHEUMATOLOGY (2004)
Increased CD40 expression in skin fibroblasts from patients with systemic sclerosis (SSc): role of CD40-CD154 in the phenotype of SSc fibroblasts
C Fukasawa et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Increased expression of CD40 ligand in activated CD4+ T lymphocytes of systemic sclerosis patients
G Valentini et al.
JOURNAL OF AUTOIMMUNITY (2000)
Share Paper
